TIMH
DXCM icon

Tilt Investment Management Holdings’s DexCom DXCM Stock Holding History

Tilt Investment Management Holdings’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,048
Closed -$263K – 136
2023
Q2 		$263K Hold
2,048
– – 0.17% 126
2023
Q1 		$238K Buy
2,048
+261
+15% +$29.2K 0.18% 132
2022
Q4 		$202K Buy
+1,787
New +$196K 0.17% 136

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Tilt Investment Management Holdings's DXCM Position: Q3 2023 in Review

Tilt Investment Management Holdings sold out of DexCom (DXCM) in Q3 2023, closing a stake of 2,048 shares — an estimated $263K sold.

Tilt Investment Management Holdings first reported a position in DXCM in Q4 2022 and held it in 3 quarters. The position peaked at $263K in Q2 2023. 904 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Tilt Investment Management Holdings reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Tilt Investment Management Holdings sold 2,048 DexCom shares in Q3 2023, an estimated $263K.
  • Tilt Investment Management Holdings first reported a position in DexCom in Q4 2022 and held it in 3 quarters.
  • Tilt Investment Management Holdings's DexCom position peaked at $263K in Q2 2023.
  • 904 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Tilt Investment Management Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.